GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents.
| Image |  |
|---|---|
| Description | scientific article published on 11 November 2017 |
| Author/s |
author: Reem Karmali |
| Publication date | November 11, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |